No Data
No Data
Tempest Therapeutics' PPARalpha Inhibitor Receives FDA Orphan Designation
Express News | Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WeatherFlow-Tempest Secures $3 Million in Growth Capital to Accelerate Innovation in Weather Technology
Favourable Signals For Tempest Therapeutics: Numerous Insiders Acquired Stock
Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference
No Data